Genetics, cognition, and neurobiology of schizotypal personality: A review of the overlap with schizophrenia

Frontiers in Psychiatry

Volumn 5, Issue FEB, 2014, Pages

  Ettinger, Ulrich ^a   Meyhöfer, Inga ^a   Steffens, Maria ^a   Wagner, Michael ^a   Koutsouleris, Nikolaos ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cognition; Genetics; Neuroimaging; Personality; Phenotype; Schizophrenia; Schizotypy; Spectrum

Indexed keywords

AMPHETAMINE; NEUROLEPTIC AGENT;

BRAIN FUNCTION; CLINICAL FEATURE; CLINICAL RESEARCH; COGNITIVE DEFECT; DOPAMINERGIC ACTIVITY; EYE MOVEMENT CONTROL; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MOLECULAR GENETICS; MOTOR CONTROL; NEUROANATOMY; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; PHENOMENOLOGY; PSYCHOMETRY; PSYCHOPHARMACOLOGY; REVIEW; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; TASK PERFORMANCE;

EID: 84895516889     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00018     Document Type: Review

References (219)

1. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 21:718-79. doi:10.1016/j.euroneuro.2011.08.008.
2. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ (2007) 10:23-41.
3. Konnopka A, Klingberg S, Wittorf A, Konig HH. The cost of schizophrenia in Germany: a systematic review of the literature. Psychiatr Prax (2009) 36:211-8. doi:10.1055/s-0028-1090234.
4. Carpenter WT, Koenig JI. The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology (2008) 33:2061-79. doi:10.1038/sj.npp.1301639.
5. David AS. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychol Med (2010) 40:1935-42. doi:10.1017/S0033291710000188.
6. Nelson MT, Seal ML, Pantelis C, Phillips LJ. Evidence of a dimensional relationship between schizotypy and schizophrenia: a systematic review. Neurosci Biobehav Rev (2013) 37:317-27. doi:10.1016/j.neubiorev.2013.01.004.
7. Rawlings D, Williams B, Haslam N, Claridge G. Taxometric analysis supports a dimensional latent trait structure for schizotypy. Pers Individ Dif (2008) 44:1640-51. doi:10.1016/j.paid.2007.06.005.
8. Murray RM, Lappin J, DiForti M. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol (2008) 18(Suppl 3):S129-34. doi:10.1016/j.euroneuro.2008.04.002.
9. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry (2000) 57:1053-8. doi:10.1001/archpsyc.57.11.1053.
10. Hafner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand Suppl (2000) 102(Suppl 407):44-8. doi:10.1034/j.1600-0447.2000.00008.x.
11. Strauss JS. Hallucinations and delusions as points on continua function. Rating scale evidence. Arch Gen Psychiatry (1969) 21:581-6. doi:10.1001/archpsyc.1969.01740230069010.
12. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med (2009) 39:179-95. doi:10.1017/S0033291708003814.
13. Sidgwick H, Johnson A, Myers FWH, Podmore F, Sidgwick EM. Report on the census of hallucinations. Proc Soc Psychical Res (1894) 10:25.
14. Tien AY. Distribution of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol (1991) 26:287-92. doi:10.1007/BF00789221.
15. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev (2001) 21:1125-41. doi:10.1016/S0272-7358(01)00103-9.
16. Rado S. Dynamics and classification of disordered behaviour. Am J Psychiatry (1953) 110:406-16.
17. Giakoumaki SG. Cognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia research. J Int Neuropsychol Soc (2012) 18:643-56.
18. Meehl PE. Schizotaxia, schizotypy, schizophrenia. Arch Gen Psychiatry (1962) 46:935-44. doi:10.1001/archpsyc.1989.01810100077015.
19. Meehl PE. Toward an integrated theory of schizotaxia. J Pers Disord (1990) 4:1-99. doi:10.1521/pedi.1990.4.1.1.
20. Meehl PE. Schizotaxia revisited. Arch Gen Psychiatry (1989) 46:935-44. doi:10.1001/archpsyc.1989.01810100077015.
21. Lenzenweger MF. Schizotypy and Schizophrenia: The View from Experimental Psychopathology. New York: Guilford Press (2010).
22. Haslam N, Holland E, Kuppens P. Categories versus dimensions in personality and psychopathology: a quantitative review of taxometric research. Psychol Med (2012) 42:903-20. doi:10.1017/S0033291711001966.
23. Claridge G. Schizotypy: Implications for Illness and Health. Oxford: OUP (1997).
24. Claridge G. The schizophrenias as nervous types. Br J Psychiatry (1972) 121:1-17. doi:10.1192/bjp.121.1.1.
25. Claridge G. The schizophrenias as nervous types revisited. Br J Psychiatry (1987) 151:735-43. doi:10.1192/bjp.151.6.735.
26. Eysenck HJ. The Biological Basis of Personality. Springfield: Charles C Thomas Publisher (1967).
27. Eysenck SB, Eysenck HJ. The measurement of psychoticism: a study of factor stability and reliability. Br J Soc Clin Psychol (1968) 7:286-94. doi:10.1111/j.2044-8260.1968.tb00571.x.
28. Barrett TR, Etheridge JB. Verbal hallucinations in normals, I: people who hear "voices". Appl Cogn Psychol (1992) 6:379-87. doi:10.1002/acp.2350060503.
29. Lincoln TM. Relevant dimensions of delusions: continuing the continuum versus category debate. Schizophr Res (2007) 93:211-20. doi:10.1016/j.schres.2007.02.013.
30. Avramopoulos D, Stefanis NC, Hantoumi I, Smyrnis N, Evdokimidis I, Stefanis CN. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele. Mol Psychiatry (2002) 7:706-11. doi:10.1038/sj.mp.4001070.
31. Lenzenweger MF, O'Driscoll GA. Smooth pursuit eye movement and schizotypy in the community. J Abnorm Psychol (2006) 115:779-86. doi:10.1037/0021-843X.115.4.779.
32. Kendler KS, Lieberman JA, Walsh D. The Structured Interview for Schizotypy (SIS): a preliminary report. Schizophr Bull (1989) 15:559-71. doi:10.1093/schbul/15.4.559.
33. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull (1991) 17:555-64. doi:10.1093/schbul/17.4.555.
34. Mason O, Claridge G. The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE): further description and extended norms. Schizophr Res (2006) 82:203-11. doi:10.1016/j.schres.2005.12.845.
35. Rust J. The rust inventory of schizotypal cognitions (RISC). Schizophr Bull (1988) 14:317-22. doi:10.1093/schbul/14.2.317.
36. Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med (2002) 32:347-58. doi:10.1017/S0033291701005141.
37. Claridge G, Broks P. Schizotypy and hemisphere function I: theoretical considerations and the measurement of schizotypy. Pers Individ Diff (1984) 5:633-48. doi:10.1016/0191-8869(84)90111-9.
38. Peters ER, Joseph SA, Garety PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters etal. Delusions Inventory). Schizophr Bull (1999) 25:553-76. doi:10.1093/oxfordjournals.schbul.a033401.
39. Eysenck HJ, Eysenck SBG. Manual of the Eysenck personality Scales (EPS Adult). London: Hodder & Stoughton (1991).
40. Chapman LJ, Kwapil TR. Scales for the measurement of schizotypy. In: Raine A, Lencz T, Mednick SA editors. Schizotypal Personality. Cambridge: Cambridge University Press (1995). p. 79-106.
41. Raine A. Schizotypal personality: neurodevelopmental and psychosocial trajectories. Annu Rev Clin Psychol (2006) 2:291-326. doi:10.1146/annurev.clinpsy.2.022305.095318.
42. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry (1987) 151:145-51. doi:10.1192/bjp.151.2.145.
43. Reynolds CA, Raine A, Mellingen K, Venables PH, Mednick SA. Three-factor model of schizotypal personality: invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophr Bull (2000) 26:603-18. doi:10.1093/oxfordjournals.schbul.a033481.
44. Gross GM, Silvia PJ, Barrantes-Vidal N, Kwapil TR. Psychometric properties and validity of short forms of the Wisconsin Schizotypy Scales in two large samples. Schizophr Res (2012) 134:267-72. doi:10.1016/j.schres.2011.11.032.
45. Konings M, Bak M, Hanssen M, van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand (2006) 114:55-61. doi:10.1111/j.1600-0447.2005.00741.x.
46. Aichert DS, Williams SC, Möller HJ, Kumari V, Ettinger U. Functional neural correlates of psychometric schizotypy: an fMRI study of antisaccades. Psychophysiology (2012) 49:345-56. doi:10.1111/j.1469-8986.2011.01306.x.
47. Corlett PR, Fletcher PC. The neurobiology of schizotypy: fronto-striatal prediction error signal correlates with delusion-like beliefs in healthy people. Neuropsychologia (2012) 50:3612-20. doi:10.1016/j.neuropsychologia.2012.09.045.
48. Debbané M, Vrticka P, Lazouret M, Badoud D, Sander D, Eliez S. Self-reflection and positive schizotypy in the adolescent brain. Schizophr Res (2014) 152:65-72. doi:10.1016/j.schres.2013.06.027.
49. Ettinger U, Corr PJ, Mofidi A, Williams SC, Kumari V. Dopaminergic basis of the psychosis-prone personality investigated with functional magnetic resonance imaging of procedural learning. Front Hum Neurosci (2013) 7:130. doi:10.3389/fnhum.2013.00130.
50. Fink A, Weber B, Koschutnig K, Benedek M, Reishofer G, Ebner F, et al. Creativity and schizotypy from the neuroscience perspective. Cogn Affect Behav Neurosci (2013). doi:10.3758/s13415-013-0210-6.
51. Huang J, Wang Y, Jin Z, Di X, Yang T, Gur RC, et al. Happy facial expression processing with different social interaction cues: an fMRI study of individuals with schizotypal personality traits. Prog Neuropsychopharmacol Biol Psychiatry (2013) 44:108-17. doi:10.1016/j.pnpbp.2013.02.004.
52. Kumari V, Antonova E, Geyer MA. Prepulse inhibition and "psychosis-proneness" in healthy individuals: an fMRI study. Eur Psychiatry (2008) 23:274-80. doi:10.1016/j.eurpsy.2007.11.006.
53. Lagioia A, Eliez S, Schneider M, Simons JS, Van der Linden M, Debbané M. Neural correlates of reality monitoring during adolescence. Neuroimage (2011) 55:1393-400. doi:10.1016/j.neuroimage.2010.12.058.
54. Lagioia A, Van DeVille D, Debbané M, Lazeyras F, Eliez S. Adolescent resting state networks and their associations with schizotypal trait expression. Front Syst Neurosci (2010) 4:35. doi:10.3389/fnsys.2010.00035.
55. Modinos G, Renken R, Shamay-Tsoory SG, Ormel J, Aleman A. Neurobiological correlates of theory of mind in psychosis proneness. Neuropsychologia (2010) 48:3715-24. doi:10.1016/j.neuropsychologia.2010.09.030.
56. Modinos G, Renken R, Ormel J, Aleman A. Self-reflection and the psychosis-prone brain: an fMRI study. Neuropsychology (2011) 25:295-305. doi:10.1037/a0021747.
57. Modinos G, Ormel J, Aleman A. Altered activation and functional connectivity of neural systems supporting cognitive control of emotion in psychosis proneness. Schizophr Res (2010) 118:88-97. doi:10.1016/j.schres.2010.01.030.
58. Mohanty A, Herrington JD, Koven NS, Fisher JE, Wenzel EA, Webb AG, et al. Neural mechanisms of affective interference in schizotypy. J Abnorm Psychol (2005) 114:16-27. doi:10.1037/0021-843X.114.1.16.
59. Premkumar P, Ettinger U, Inchley-Mort S, Sumich A, Williams SC, Kuipers E, et al. Neural processing of social rejection: the role of schizotypal personality traits. Hum Brain Mapp (2012) 33:695-706. doi:10.1002/hbm.21243.
60. Cardno AG, Marshall EJ, Coid B, MacDonald AM, Ribchester TR, Davies NJ, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 56:162-8. doi:10.1001/archpsyc.56.2.162.
61. Claridge G, Hewitt J. A biometrical study of schizotypy in a normal population. Pers Individ Diff (1987) 8:303-12. doi:10.1016/0191-8869(87)90030-4.
62. Linney YM, Murray RM, Peters ER, MacDonald AM, Rijsdijk F, Sham PC. A quantitative genetic analysis of schizotypal personality traits. Psychol Med (2003) 33:803-16. doi:10.1017/S0033291703007906.
63. Macare C, Bates TC, Heath AC, Martin NG, Ettinger U. Substantial genetic overlap between schizotypy and neuroticism: a twin study. Behav Genet (2012) 42:732-42. doi:10.1007/s10519-012-9558-6.
64. Kendler KS, Hewitt J. The structure of self-report schizotypy in twins. J Pers Disord (1992) 6:1-17. doi:10.1521/pedi.1992.6.1.1.
65. MacDonald AW, Pogue-Geile MF, Debski TT, Manuck S. Genetic and environmental influences on schizotypy: a community-based twin study. Schizophr Bull (2001) 27:47-58. doi:10.1093/oxfordjournals.schbul.a006859.
66. Calkins ME, Curtis CE, Grove WM, Iacono WG. Multiple dimensions of schizotypy in first degree biological relatives of schizophrenia patients. Schizophr Bull (2004) 30:317-25. doi:10.1093/oxfordjournals.schbul.a007081.
67. Yaralian PS, Raine A, Lencz T, Hooley JM, Bihrle SE, Mills S, et al. Elevated levels of cognitive-perceptual deficits in individuals with a family history of schizophrenia spectrum disorders. Schizophr Res (2000) 46:57-63. doi:10.1016/S0920-9964(99)00239-X.
68. Tarbox SI, Pogue-Geile MF. A multivariate perspective on schizotypy and familial association with schizophrenia: a review. Clin Psychol Rev (2011) 31:1169-82. doi:10.1016/j.cpr.2011.07.002.
69. Mata I, Gilvarry CM, Jones PB, Lewis SW, Murray RM, Sham PC. Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. Schizophr Bull (2003) 29:273-83. doi:10.1093/oxfordjournals.schbul.a007004.
70. Fanous A, Gardner C, Walsh D, Kendler KS. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch Gen Psychiatry (2001) 58:669-73. doi:10.1001/archpsyc.58.7.669.
71. Fanous AH, Neale MC, Gardner CO, Webb BT, Straub RE, O'Neill FA, et al. Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol Psychiatry (2007) 12:958-65. doi:10.1038/sj.mp.4001996.
72. Bolinskey PK, Iati CA, Hunter HK, Novi JH. Season of birth, mixed-handedness, and psychometric schizotypy: preliminary results from a prospective study. Psychiatry Res (2013) 208:210-4. doi:10.1016/j.psychres.2012.12.023.
73. Krabbendam L, van Os J. Schizophrenia and urbanicity: a major environmental influence-conditional on genetic risk. Schizophr Bull (2005) 31:795-9. doi:10.1093/schbul/sbi060.
74. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry (2005) 162:12-24. doi:10.1176/appi.ajp.162.1.12.
75. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand (2005) 112:330-50. doi:10.1111/j.1600-0447.2005.00634.x.
76. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull (2005) 31:608-12. doi:10.1093/schbul/sbi027.
77. Keefe RS, Harvey PD. Cognitive impairment in schizophrenia. Handb Exp Pharmacol (2012) 213:11-37. doi:10.1007/978-3-642-25758-2_2.
78. Chun CA, Minor KS, Cohen AS. Neurocognition in psychometrically defined college schizotypy samples: we are not measuring the "right stuff". J Int Neuropsychol Soc (2013) 19:324-37. doi:10.1017/S135561771200152X.
79. Park S, Holzman PS, Lenzenweger MF. Individual differences in spatial working memory in relation to schizotypy. J Abnorm Psychol (1995) 104:355-63. doi:10.1037/0021-843X.104.2.355.
80. Park S, McTigue K. Working memory and the syndromes of schizotypal personality. Schizophr Res (1997) 26:213-20. doi:10.1016/S0920-9964(97)00051-0.
81. Koychev I, El-Deredy W, Haenschel C, Deakin JF. Visual information processing deficits as biomarkers of vulnerability to schizophrenia: an event-related potential study in schizotypy. Neuropsychologia (2010) 48:2205-14. doi:10.1016/j.neuropsychologia.2010.04.014.
82. Kerns JG, Becker TM. Communication disturbances, working memory, and emotion in people with elevated disorganized schizotypy. Schizophr Res (2008) 100:172-80. doi:10.1016/j.schres.2007.11.005.
83. Matheson S, Langdon R. Schizotypal traits impact upon executive working memory and aspects of IQ. Psychiatry Res (2008) 159:207-14. doi:10.1016/j.psychres.2007.04.006.
84. Tallent KA, Gooding DC. Working memory and Wisconsin Card Sorting Test performance in schizotypic individuals: a replication and extension. Psychiatry Res (1999) 89:161-70. doi:10.1016/S0165-1781(99)00101-8.
85. Gooding DC, Kwapil TR, Tallent KA. Wisconsin Card Sorting Test deficits in schizotypic individuals. Schizophr Res (1999) 40:201-9. doi:10.1016/S0920-9964(99)00124-3.
86. Raine A, Sheard C, Reynolds GP, Lencz T. Pre-frontal structural and functional deficits associated with individual differences in schizotypal personality. Schizophr Res (1992) 7:237-47. doi:10.1016/0920-9964(92)90018-Z.
87. Cappe C, Herzog MH, Herzig DA, Brand A, Mohr C. Cognitive disorganisation in schizotypy is associated with deterioration in visual backward masking. Psychiatry Res (2012) 200:652-9. doi:10.1016/j.psychres.2012.07.001.
88. Cochrane M, Petch I, Pickering AD. Aspects of cognitive functioning in schizotypy and schizophrenia: evidence for a continuum model. Psychiatry Res (2012) 196:230-4. doi:10.1016/j.psychres.2012.02.010.
89. Swerdlow NR, Filion D, Geyer MA, Braff DL. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol Psychiatry (1995) 37:286-99. doi:10.1016/0006-3223(94)00138-S.
90. Kumari V, Toone B, Gray JA. Habituation and prepulse inhibition of the acoustic startle reflex: effects of smoking status and psychosis-proneness. Pers Individ Diff (1997) 23:183-91. doi:10.1016/S0191-8869(97)00045-7.
91. Takahashi H, Iwase M, Canuet L, Yasuda Y, Ohi K, Fukumoto M, et al. Relationship between prepulse inhibition of acoustic startle response and schizotypy in healthy Japanese subjects. Psychophysiology (2010) 47:831-7. doi:10.1111/j.1469-8986.2010.01000.x.
92. Völter C, Strobach T, Aichert DS, Wöstmann N, Costa A, Möller HJ, et al. Schizotypy and behavioural adjustment and the role of neuroticism. PLoS One (2012) 7:e30078. doi:10.1371/journal.pone.0030078.
93. Kumari V, Ettinger U. Cognition, neuroscience, and applications to schizophrenia. In: Lubow RE editor. Latent Inhibition. Cambridge: Cambridge University Press (2010). p. 419-47.
94. Brown LA, Cohen AS. Facial emotion recognition in schizotypy: the role of accuracy and social cognitive bias. J Int Neuropsychol Soc (2010) 16:474-83. doi:10.1017/S135561771000007X.
95. Germine LT, Hooker CI. Face emotion recognition is related to individual differences in psychosis-proneness. Psychol Med (2011) 41:937-47. doi:10.1017/S0033291710001571.
96. Bedwell JS, Kamath V, Baksh E. Comparison of three computer-administered cognitive tasks as putative endophenotypes of schizophrenia. Schizophr Res (2006) 88:36-46. doi:10.1016/j.schres.2006.08.002.
97. Bergida H, Lenzenweger MF. Schizotypy and sustained attention: confirming evidence from an adult community sample. J Abnorm Psychol (2006) 115:545-51. doi:10.1037/0021-843X.115.3.545.
98. Langdon R, Coltheart M. Visual perspective-taking and schizotypy: evidence for a simulation-based account of mentalizing in normal adults. Cognition (2001) 82:1-26. doi:10.1016/S0010-0277(01)00139-1.
99. Arzy S, Mohr C, Michel CM, Blanke O. Duration and not strength of activation in temporo-parietal cortex positively correlates with schizotypy. Neuroimage (2007) 35:326-33. doi:10.1016/j.neuroimage.2006.11.027.
100. Mohr C, Landis T, Brugger P. Lateralized semantic priming: modulation by levodopa, semantic distance, and participants' magical beliefs. Neuropsychiatr Dis Treat (2006) 2:71-84.
101. Morrison SC, Brown LA, Cohen AS. A multidimensional assessment of social cognition in psychometrically defined schizotypy. Psychiatry Res (2013) 210:1014-9. doi:10.1016/j.psychres.2013.08.020.
102. Bates TC. The panmodal sensory imprecision hypothesis of schizophrenia: reduced auditory precision in schizotypy. Pers Individ Diff (2005) 38:437-49. doi:10.1016/j.paid.2004.04.021.
103. Park S, Schoppe S. Olfactory identification deficit in relation to schizotypy. Schizophr Res (1997) 26:191-7. doi:10.1016/S0920-9964(97)00045-5.
104. Obiols JE, Serrano F, Caparrós B, Subirá S, Barrantes N. Neurological soft signs in adolescents with poor performance on the continuous performance test: markers of liability for schizophrenia spectrum disorders? Psychiatry Res (1999) 86:217-28. doi:10.1016/S0165-1781(99)00039-6.
105. Barkus E, Stirling J, Hopkins R, Lewis S. The presence of neurological soft signs along the psychosis proneness continuum. Schizophr Bull (2006) 32:573-7. doi:10.1093/schbul/sbj037.
106. Mohr C, Landis T, Sandor PS, Fathi M, Brugger P. Nonstereotyped responding in positive schizotypy after a single dose of levodopa. Neuropsychopharmacology (2004) 29:1741-51. doi:10.1038/sj.npp.1300500.
107. Lenzenweger MF, Maher BA. Psychometric schizotypy and motor performance. J Abnorm Psychol (2002) 111:546-55. doi:10.1037/0021-843X.111.4.546.
108. O'Driscoll GA, Callahan BL. Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993. Brain Cogn (2008) 68:359-70. doi:10.1016/j.bandc.2008.08.023.
109. Gooding DC, Basso MA. The tell-tale tasks: a review of saccadic research in psychiatric patient populations. Brain Cogn (2008) 68:371-90. doi:10.1016/j.bandc.2008.08.024.
110. Ettinger U, Kumari V, Crawford TJ, Flak V, Sharma T, Davis RE, et al. Saccadic eye movements, schizotypy, and the role of neuroticism. Biol Psychol (2005) 68:61-78. doi:10.1016/j.biopsycho.2004.03.014.
111. Gooding DC. Antisaccade task performance in questionnaire-identified schizotypes. Schizophr Res (1999) 35:157-66. doi:10.1016/S0920-9964(98)00120-0.
112. O'Driscoll GA, Lenzenweger MF, Holzman PS. Antisaccades and smooth pursuit eye tracking and schizotypy. Arch Gen Psychiatry (1998) 55:837-43. doi:10.1001/archpsyc.55.9.837.
113. Kendler KS, Ochs AL, Gorman AM, Hewitt JK, Ross DE, Mirsky AF. The structure of schizotypy: a pilot multitrait twin study. Psychiatry Res (1991) 36:19-36. doi:10.1016/0165-1781(91)90114-5.
114. Gooding DC, Miller MD, Kwapil TR. Smooth pursuit eye tracking and visual fixation in psychosis-prone individuals. Psychiatry Res (2000) 93:41-54. doi:10.1016/S0165-1781(00)00113-X.
115. Holahan ALV, O'Driscoll GA. Antisaccade and smooth pursuit performance in positive- and negative-symptom schizotypy. Schizophr Res (2005) 76:43-54. doi:10.1016/j.schres.2004.10.005.
116. Barrantes-Vidal N, Fañanás L, Rosa A, Caparrós B, Dolors RibaM, Obiols JE. Neurocognitive, behavioural and neurodevelopmental correlates of schizotypy clusters in adolescents from the general population. Schizophr Res (2003) 61:293-302. doi:10.1016/S0920-9964(02)00321-3.
117. Dinn WM, Harris CL, Aycicegi A, Greene P, Andover MS. Positive and negative schizotypy in a student sample: neurocognitive and clinical correlates. Schizophr Res (2002) 56:171-85. doi:10.1016/S0920-9964(01)00230-4.
118. Suhr JA, Spitznagel MB. Factor versus cluster models of schizotypal traits. II: relation to neuropsychological impairment. Schizophr Res (2001) 52:241-50. doi:10.1016/S0920-9964(00)00185-7.
119. Moritz S, Andresen B. Reduced negative priming in schizotypy: failure to replicate. Br J Clin Psychol (2004) 43:211-5. doi:10.1348/014466504323088060.
120. Cimino M, Haywood M. Inhibition and facilitation in schizotypy. J Clin Exp Neuropsychol (2008) 30:187-98. doi:10.1080/13803390701336866.
121. Martin EA, Kerns JG. Social anhedonia associated with poor evaluative processing but not with poor cognitive control. Psychiatry Res (2010) 178:419-24. doi:10.1016/j.psychres.2009.08.018.
122. Kaplan O, Lubow RE. Ignoring irrelevant stimuli in latent inhibition and Stroop paradigms: the effects of schizotypy and gender. Psychiatry Res (2011) 186:40-5. doi:10.1016/j.psychres.2010.07.025.
123. Wan L, Friedman BH, Boutros NN, Crawford HJ. P50 sensory gating and attentional performance. Int J Psychophysiol (2008) 67:91-100. doi:10.1016/j.ijpsycho.2007.10.008.
124. Szöke A, Méary A, Ferchiou A, Trandafir A, Leboyer M, Schürhoff F. Correlations between cognitive performances and psychotic or schizotypal dimensions. Eur Psychiatry (2009) 24:244-50. doi:10.1016/j.eurpsy.2008.10.007.
125. Suhr JA. Executive functioning deficits in hypothetically psychosis-prone college students. Schizophr Res (1997) 27:29-35. doi:10.1016/S0920-9964(97)00072-8.
126. Orem DM, Bedwell JS. A preliminary investigation on the relationship between color-word Stroop task performance and delusion-proneness in nonpsychiatric adults. Psychiatry Res (2010) 175:27-32. doi:10.1016/j.psychres.2008.09.001.
127. Weinstein S, Graves RE. Are creativity and schizotypy products of a right hemisphere bias? Brain Cogn (2002) 49:138-51. doi:10.1006/brcg.2001.1493.
128. Nettle D, Clegg H. Schizotypy, creativity and mating success in humans. Proc Biol Sci (2006) 273:611-5. doi:10.1098/rspb.2005.3349.
129. Folley BS, Park S. Verbal creativity and schizotypal personality in relation to prefrontal hemispheric laterality: a behavioral and near-infrared optical imaging study. Schizophr Res (2005) 80:271-82. doi:10.1016/j.schres.2005.06.016.
130. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 2:924-6. doi:10.1016/S0140-6736(76)90890-4.
131. Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci (2010) 12:317-32.
132. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev (2012) 36:1342-56. doi:10.1016/j.neubiorev.2011.12.015.
133. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry (1999) 46:908-20. doi:10.1016/S0006-3223(99)00152-3.
134. Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull (2009) 35:509-27. doi:10.1093/schbul/sbn176.
135. Uhlhaas PJ. Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia. Curr Opin Neurobiol (2013) 23:283-90. doi:10.1016/j.conb.2012.11.004.
136. Modinos G, Mechelli A, Ormel J, Groenewold NA, Aleman A, McGuire PK. Schizotypy and brain structure: a voxel-based morphometry study. Psychol Med (2010) 40:1423-31. doi:10.1017/S0033291709991875.
137. Kuhn S, Schubert F, Gallinat J. Higher prefrontal cortical thickness in high schizotypal personality trait. J Psychiatr Res (2012) 46:960-5. doi:10.1016/j.jpsychires.2012.04.007.
138. Ettinger U, Chitnis XA, Kumari V, Fannon DG, Sumich AL, O'Ceallaigh S, et al. Magnetic resonance imaging of the thalamus in first-episode psychosis. Am J Psychiatry (2001) 158:116-8. doi:10.1176/appi.ajp.158.1.116.
139. Ettinger U, Picchioni M, Landau S, Matsumoto K, van Haren NE, Marshall N, et al. Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Arch Gen Psychiatry (2007) 64:401-9. doi:10.1001/archpsyc.64.4.401.
140. Ettinger U, Williams SC, Meisenzahl EM, Möller HJ, Kumari V, Koutsouleris N. Association between brain structure and psychometric schizotypy in healthy individuals. World J Biol Psychiatry (2012) 13:544-9. doi:10.3109/15622975.2011.559269.
141. Volpe U, Federspiel A, Mucci A, Dierks T, Frank A, Wahlund LO, et al. Cerebral connectivity and psychotic personality traits. A diffusion tensor imaging study. Eur Arch Psychiatry Clin Neurosci (2008) 258:292-9. doi:10.1007/s00406-007-0796-1.
142. Nelson MT, Seal ML, Phillips LJ, Merritt AH, Wilson R, Pantelis C. An investigation of the relationship between cortical connectivity and schizotypy in the general population. J Nerv Ment Dis (2011) 199:348-53. doi:10.1097/NMD.0b013e318217514b.
143. Asami T, Whitford TJ, Bouix S, Dickey CC, Niznikiewicz M, Shenton ME, et al. Globally and locally reduced MRI gray matter volumes in neuroleptic-naive men with schizotypal personality disorder: association with negative symptoms. JAMA Psychiatry (2013) 70:361-72. doi:10.1001/jamapsychiatry.2013.665.
144. Hazlett EA, Goldstein KE, Kolaitis JC. A review of structural MRI and diffusion tensor imaging in schizotypal personality disorder. Curr Psychiatry Rep (2012) 14:70-8. doi:10.1007/s11920-011-0241-z.
145. Byne W, Buchsbaum MS, Kemether E, Hazlett EA, Shinwari A, Mitropoulou V, et al. Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry (2001) 58:133-40. doi:10.1001/archpsyc.58.2.133.
146. Kumari V, Gray JA, Geyer MA, Ffytche D, Soni W, Mitterschiffthaler MT, et al. Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res (2003) 122:99-113. doi:10.1016/S0925-4927(02)00123-3.
147. Kumari V, Antonova E, Geyer MA, Ffytche D, Williams SC, Sharma T. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol (2007) 10:463-77. doi:10.1017/S1461145706007139.
148. Corlett PR, Murray GK, Honey GD, Aitken MR, Shanks DR, Robbins TW, et al. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain (2007) 130:2387-400. doi:10.1093/brain/awm173.
149. Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, et al. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry (2006) 63:611-21. doi:10.1001/archpsyc.63.6.611.
150. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 51:199-214. doi:10.1001/archpsyc.1994.03950030035004.
151. Crawford TJ, Puri BK, Nijran KS, Jones B, Kennard C, Lewis SW. Abnormal saccadic distractibility in patients with schizophrenia: a 99mTc-HMPAO SPET study. Psychol Med (1996) 26:265-77. doi:10.1017/S0033291700034668.
152. McDowell JE, Brown GG, Paulus M, Martinez A, Stewart SE, Dubowitz DJ, et al. Neural correlates of refixation saccades and antisaccades in normal and schizophrenia subjects. Biol Psychiatry (2002) 51:216-23. doi:10.1016/S0006-3223(01)01204-5.
153. Raemaekers M, Jansma JM, Cahn W, Van der Geest JN, van der Linden JA, Kahn RS, et al. Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Arch Gen Psychiatry (2002) 59:313-20. doi:10.1001/archpsyc.59.4.313.
154. Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS. Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biol Psychiatry (2006) 59:530-5. doi:10.1016/j.biopsych.2005.07.030.
155. Camchong J, Dyckman KA, Austin BP, Clementz BA, McDowell JE. Common neural circuitry supporting volitional saccades and its disruption in schizophrenia patients and relatives. Biol Psychiatry (2008) 64:1042-50. doi:10.1016/j.biopsych.2008.06.015.
156. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature (2010) 468:203-12. doi:10.1038/nature09563.
157. Soliman A, O'Driscoll GA, Pruessner J, Joober R, Ditto B, Streicker E, et al. Limbic response to psychosocial stress in schizotypy: a functional magnetic resonance imaging study. Schizophr Res (2011) 131:184-91. doi:10.1016/j.schres.2011.05.016.
158. Soliman A, O'Driscoll GA, Pruessner J, Holahan AL, Boileau I, Gagnon D, et al. Stress-induced dopamine release in humans at risk of psychosis: a [11C]raclopride PET study. Neuropsychopharmacology (2008) 33:2033-41. doi:10.1038/sj.npp.1301597.
159. Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol (2008) 21:424-30. doi:10.1097/WCO.0b013e328306f2c5.
160. Koenigsberg HW, Buchsbaum MS, Buchsbaum BR, Schneiderman JS, Tang CY, New A, et al. Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis. Psychol Med (2005) 35:1019-30. doi:10.1017/S0033291705004393.
161. Dickey CC, Morocz IA, Niznikiewicz MA, Voglmaier M, Toner S, Khan U, et al. Auditory processing abnormalities in schizotypal personality disorder: an fMRI experiment using tones of deviant pitch and duration. Schizophr Res (2008) 103:26-39. doi:10.1016/j.schres.2008.04.041.
162. Dickey CC, Morocz IA, Minney D, Niznikiewicz MA, Voglmaier MM, Panych LP, et al. Factors in sensory processing of prosody in schizotypal personality disorder: an fMRI experiment. Schizophr Res (2010) 121:75-89. doi:10.1016/j.schres.2010.03.008.
163. Haenschel C, Bittner RA, Haertling F, Rotarska-Jagiela A, Maurer K, Singer W, et al. Contribution of impaired early-stage visual processing to working memory dysfunction in adolescents with schizophrenia: a study with event-related potentials and functional magnetic resonance imaging. Arch Gen Psychiatry (2007) 64:1229-40. doi:10.1001/archpsyc.64.11.1229.
164. Klein C, Berg P, Rockstroh B, Andresen B. Topography of the auditory P300 in schizotypal personality. Biol Psychiatry (1999) 45:1612-21. doi:10.1016/S0006-3223(98)00254-6.
165. Winterer G, Goldman D. Genetics of human prefrontal function. Brain Res Brain Res Rev (2003) 43:134-63. doi:10.1016/S0165-0173(03)00205-4.
166. Prévost M, Rodier M, Renoult L, Kwann Y, Dionne-Dostie E, Chapleau I, et al. Schizotypal traits and N400 in healthy subjects. Psychophysiology (2010) 47:1047-56. doi:10.1111/j.1469-8986.2010.01016.x.
167. Koychev I, Deakin JF, Haenschel C, El-Deredy W. Abnormal neural oscillations in schizotypy during a visual working memory task: support for a deficient top-down network? Neuropsychologia (2011) 49:2866-73. doi:10.1016/j.neuropsychologia.2011.06.012.
168. Mohr C, Blanke O, Brugger P. Perceptual aberrations impair mental own-body transformations. Behav Neurosci (2006) 120:528-34. doi:10.1037/0735-7044.120.3.528.
169. Croft RJ, Lee A, Bertolot J, Gruzelier JH. Associations of P50 suppression and desensitization with perceptual and cognitive features of "unreality" in schizotypy. Biol Psychiatry (2001) 50:441-6. doi:10.1016/S0006-3223(01)01082-4.
170. Wang J, Miyazato H, Hokama H, Hiramatsu K, Kondo T. Correlation between P50 suppression and psychometric schizotypy among non-clinical Japanese subjects. Int J Psychophysiol (2004) 52:147-57. doi:10.1016/j.ijpsycho.2003.06.001.
171. Evans LH, Gray NS, Snowden RJ. Reduced P50 suppression is associated with the cognitive disorganisation dimension of schizotypy. Schizophr Res (2007) 97:152-62. doi:10.1016/j.schres.2007.07.019.
172. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry (2000) 157:55-9.
173. Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry (1998) 155:1691-4.
174. Platek SM, Fonteyn LC, Izzetoglu M, Myers TE, Ayaz H, Li C, et al. Functional near infrared spectroscopy reveals differences in self-other processing as a function of schizotypal personality traits. Schizophr Res (2005) 73:125-7. doi:10.1016/j.schres.2004.09.024.
175. Hori H, Ozeki Y, Terada S, Kunugi H. Functional near-infrared spectroscopy reveals altered hemispheric laterality in relation to schizotypy during verbal fluency task. Prog Neuropsychopharmacol Biol Psychiatry (2008) 32:1944-51. doi:10.1016/j.pnpbp.2008.09.019.
176. Hori H, Nagamine M, Soshi T, Okabe S, Kim Y, Kunugi H. Schizotypal traits in healthy women predict prefrontal activation patterns during a verbal fluency task: a near-infrared spectroscopy study. Neuropsychobiology (2008) 57:61-9. doi:10.1159/000129669.
177. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 94:2569-74. doi:10.1073/pnas.94.6.2569.
178. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry (1999) 46:56-72. doi:10.1016/S0006-3223(99)00067-0.
179. Abi-Dargham A, Kegeles LS, Zea-Ponce Y, Mawlawi O, Martinez D, Mitropoulou V, et al. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 55:1001-6. doi:10.1016/j.biopsych.2004.01.018.
180. Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, Li R, et al. Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. Am J Psychiatry (2011) 168:418-26. doi:10.1176/appi.ajp.2010.10020165.
181. Koychev I, McMullen K, Lees J, Dadhiwala R, Grayson L, Perry C, et al. A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study. Eur Neuropsychopharmacol (2012) 22:469-81. doi:10.1016/j.euroneuro.2011.10.005.
182. Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, et al. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology (Berl) (2013) 227:331-45. doi:10.1007/s00213-013-2973-4.
183. Burke JG, Reveley MA. Improved antisaccade performance with risperidone in schizophrenia. J Neurol Neurosurg Psychiatry (2002) 72:449-54.
184. Harris MS, Reilly JL, Keshavan MS, Sweeney JA. Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med (2006) 36:485-94. doi:10.1017/S0033291705006756.
185. Debruille JB, Rodier M, Prévost M, Lionnet C, Molavi S. Effects of a small dose of olanzapine on healthy subjects according to their schizotypy: an ERP study using a semantic categorization and an oddball task. Eur Neuropsychopharmacol (2013) 23:339-50. doi:10.1016/j.euroneuro.2012.06.005.
186. Condray R, Steinhauer SR, Cohen JD, van Kammen DP, Kasparek A. Modulation of language processing in schizophrenia: effects of context and haloperidol on the event-related potential. Biol Psychiatry (1999) 45:1336-55. doi:10.1016/S0006-3223(98)00317-5.
187. Condray R, Siegle GJ, Cohen JD, van Kammen DP, Steinhauer SR. Automatic activation of the semantic network in schizophrenia: evidence from event-related brain potentials. Biol Psychiatry (2003) 54:1134-48. doi:10.1016/S0006-3223(03)00699-1.
188. Nothen MM, Nieratschker V, Cichon S, Rietschel M. New findings in the genetics of major psychoses. Dialogues Clin Neurosci (2010) 12:85-93.
189. Brune M. Schizophrenia-an evolutionary enigma? Neurosci Biobehav Rev (2004) 28:41-53. doi:10.1016/j.neubiorev.2003.10.002.
190. Esterberg ML, Compton MT. The psychosis continuum and categorical versus dimensional diagnostic approaches. Curr Psychiatry Rep (2009) 11:179-84. doi:10.1007/s11920-009-0028-7.
191. Larrison AL, Briand KA, Sereno AB. Nicotine, caffeine, alcohol and schizotypy. Pers Individ Diff (1999) 27:101-8. doi:10.1016/S0191-8869(98)00217-7.
192. Williams JH, Wellman NA, Rawlins JN. Tobacco smoking correlates with schizotypal and borderline personality traits. Pers Individ Diff (1996) 20:267-70. doi:10.1016/0191-8869(95)00179-4.
193. Williams JH, Wellman NA, Rawlins JN. Cannabis use correlates with schizotypy in healthy people. Addiction (1996) 91:869-77. doi:10.1111/j.1360-0443.1996.tb03581.x.
194. Fridberg DJ, Vollmer JM, O'Donnell BF, Skosnik PD. Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res (2011) 186:46-52. doi:10.1016/j.psychres.2010.07.035.
195. Kwapil TR, Brown LH, Silvia PJ, Myin-Germeys I, Barrantes-Vidal N. The expression of positive and negative schizotypy in daily life: an experience sampling study. Psychol Med (2012) 42:2555-66. doi:10.1017/S0033291712000827.
196. Lewandowski KE, Barrantes-Vidal N, Nelson-Gray RO, Clancy C, Kepley HO, Kwapil TR. Anxiety and depression symptoms in psychometrically identified schizotypy. Schizophr Res (2006) 83:225-35. doi:10.1016/j.schres.2005.11.024.
197. Seghers JP, McCleery A, Docherty NM. Schizotypy, alexithymia, and socioemotional outcomes. J Nerv Ment Dis (2011) 199:117-21. doi:10.1097/NMD.0b013e3182083bc4.
198. Berenbaum H, Valera EM, Kerns JG. Psychological trauma and schizotypal symptoms. Schizophr Bull (2003) 29:143-52. doi:10.1093/oxfordjournals.schbul.a006985.
199. Martin EA, Bailey DH, Cicero DC, Kerns JG. Social networking profile correlates of schizotypy. Psychiatry Res (2012) 200:641-6. doi:10.1016/j.psychres.2012.06.031.
200. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry (2011) 168:800-5. doi:10.1176/appi.ajp.2011.10081191.
201. Blanchard JJ, Collins LM, Aghevli M, Leung WW, Cohen AS. Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy. Schizophr Bull (2011) 37:587-602. doi:10.1093/schbul/sbp107.
202. Fonseca-Pedrero E, Paino M, Lemos-Giraldez S, Muniz J. Schizotypal traits and depressive symptoms in nonclinical adolescents. Compr Psychiatry (2011) 52:293-300. doi:10.1016/j.comppsych.2010.07.001.
203. Henry JD, Bailey PE, Rendell PG. Empathy, social functioning and schizotypy. Psychiatry Res (2008) 160:15-22. doi:10.1016/j.psychres.2007.04.014.
204. Jahshan CS, Sergi MJ. Theory of mind, neurocognition, and functional status in schizotypy. Schizophr Res (2007) 89:278-86. doi:10.1016/j.schres.2006.09.004.
205. Aguirre F, Sergi MJ, Levy CA. Emotional intelligence and social functioning in persons with schizotypy. Schizophr Res (2008) 104:255-64. doi:10.1016/j.schres.2008.05.007.
206. Barrantes-Vidal N, Lewandowski KE, Kwapil TR. Psychopathology, social adjustment and personality correlates of schizotypy clusters in a large nonclinical sample. Schizophr Res (2010) 122:219-25. doi:10.1016/j.schres.2010.01.006.
207. Thaker G, Adami H, Gold J. Functional deterioration in individuals with schizophrenia spectrum personality symptoms. J Pers Disord (2001) 15:229-34. doi:10.1521/pedi.15.3.229.19207.
208. Cohen AS, Davis TE III. Quality of life across the schizotypy spectrum: findings from a large nonclinical adult sample. Compr Psychiatry (2009) 50:408-14. doi:10.1016/j.comppsych.2008.11.002.
209. Koychev I, Barkus E, Ettinger U, Killcross S, Roiser JP, Wilkinson L, et al. Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. J Psychopharmacol (2011) 25:1207-25. doi:10.1177/0269881111414450.
210. Dourish CT, Dawson GR. Precompetitive consortium approach to validation of the next generation of biomarkers in schizophrenia. Biomark Med (2014) 8:5-8. doi:10.2217/bmm.13.89.
211. Kraemer HC, Noda A, O'Hara R. Categorical versus dimensional approaches to diagnosis: methodological challenges. J Psychiatr Res (2004) 38:17-25. doi:10.1016/S0022-3956(03)00097-9.
212. Markon KE, Chmielewski M, Miller CJ. The reliability and validity of discrete and continuous measures of psychopathology: a quantitative review. Psychol Bull (2011) 137:856-79. doi:10.1037/a0023678.
213. Kety SS. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology. Am J Psychiatry (1983) 140:720-7.
214. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 160:636-45. doi:10.1176/appi.ajp.160.4.636.
215. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci (2006) 7:818-27. doi:10.1038/nrn1993.
216. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 70:107-20. doi:10.1001/jamapsychiatry.2013.269.
217. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol (1994) 103:171-83. doi:10.1037/0021-843X.103.2.171.
218. Barrantes-Vidal N, Gross GM, Sheinbaum T, Mitjavila M, Ballespí S, Kwapil TR. Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms. Schizophr Res (2013) 145:50-5. doi:10.1016/j.schres.2013.01.007.
219. Lin A, Wigman JT, Nelson B, Wood SJ, Vollebergh WA, van Os J, et al. Follow-up factor structure of schizotypy and its clinical associations in a help-seeking sample meeting ultra-high risk for psychosis criteria at baseline. Compr Psychiatry (2013) 54:173-80. doi:10.1016/j.comppsych.2012.06.011.